Post-Cycle Therapy (PCT) (94 Offers)
CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 100 TABLETS x 20 MG
ACTIVE HALF-LIFE: 5–7 DAYS
DOSAGE: 20–40 MG/DAY (PCT)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
SELECTIVE ESTROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 30 PILLS x 20 MG
ACTIVE HALF-LIFE: 5 DAYS
DOSAGE: MEN 20-120 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: VERY LOW
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 100 TABLETS x 1 MG
ACTIVE HALF-LIFE: 46 HOURS
DOSAGE: 0.5–1 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: REDUCED
HIGH BLOOD PRESSURE (HBP): REDUCED
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON
CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 50 TABLETS × 1 MG
ACTIVE HALF-LIFE: ~48 HOURS
DOSAGE: MEN 0.5–1 MG EVERY OTHER DAY
ACNE: REDUCED RISK
WATER RETENTION: PREVENTED
HIGH BLOOD PRESSURE (HBP): LESS LIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 50 TABLETS × 25 MG
ACTIVE HALF-LIFE: 24–30 HOURS
DOSAGE: MEN 12.5–25 MG/DAY OR EOD
ACNE: REDUCED
WATER RETENTION: MINIMAL
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: LOW
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 TABLETS × 2.5 MG
ACTIVE HALF-LIFE: ~2 DAYS
DOSAGE: MEN 0.5–2.5 MG/DAY
ACNE: REDUCED
WATER RETENTION: MINIMIZED
HIGH BLOOD PRESSURE (HBP): LOW RISK
HEPATOTOXICITY: NONE
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
CLASSIFICATION: SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 50 TABLETS × 20 MG
ACTIVE HALF-LIFE: ~5–7 DAYS
DOSAGE: MEN 10–40 MG/DAY
ACNE: NO
WATER RETENTION: REDUCED
HIGH BLOOD PRESSURE (HBP): LOW RISK
HEPATOTOXICITY: LOW
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
CLASSIFICATION: SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)
ACTIVE SUBSTANCE: CLOMIPHENE CITRATE
FORM: 50 TABLETS × 50 MG
ACTIVE HALF-LIFE: ~5–7 DAYS
DOSAGE: MEN 50–100 MG/DAY
ACNE: NO
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 50 TABLETS x 1 MG
ACTIVE HALF-LIFE: ~48 HOURS
DOSAGE: 0.5–1 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: SERM (SELECTIVE ESTROGEN RECEPTOR MODULATOR)
ACTIVE SUBSTANCE: CLOMIPHENE CITRATE
FORM: 50 TABLETS x 50 MG
ACTIVE HALF-LIFE: 5-7 DAYS
DOSAGE: MEN 25–100 MG/DAY
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: EXEMESTANE
FORM: 50 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~24 HOURS
DOSAGE: 12.5–25 MG/DAY OR EOD
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): REDUCED RISK
HEPATOTOXICITY: NO
AROMATIZATION: PERMANENTLY BLOCKED
MANUFACTURER: AXIOLABS
CLASSIFICATION: AROMATASE INHIBITOR; ANTIESTROGEN
ACTIVE SUBSTANCE: LETROZOLE
FORM: 50 TABLETS x 2.5 MG
ACTIVE HALF-LIFE: 2 DAYS
DOSAGE: 0.25–1.25 MG EVERY OTHER DAY
ACNE: REDUCED
WATER RETENTION: SIGNIFICANTLY REDUCED
HIGH BLOOD PRESSURE (HBP): DECREASED RISK
HEPATOTOXICITY: NO
AROMATIZATION: BLOCKED (POTENT)
MANUFACTURER: AXIOLABS
CLASSIFICATION: GONADOTROPIN (LH RECEPTOR AGONIST)
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 LYOPHILIZED VIAL x 5000 IU + PROVIDED SOLVENT
ACTIVE HALF-LIFE: ~24–36 HOURS
DOSAGE: MEN 500-1000 IU
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MONITOR IF AT CV RISK
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: INDIRECT
MANUFACTURER: IBSA
CLASSIFICATION: GONADOTROPIN PEPTIDE HORMONE
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 2 ML VIAL (5000 IU/VIAL)
ACTIVE HALF-LIFE: ~ 36 HOURS
DOSAGE: 500-1500 IU 2-3 TIMES WEEKLY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT COMMON
HEPATOTOXICITY: NO
AROMATIZATION: INDIRECTLY POSSIBLE
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 100 TABLETS (2 MG/TABLET)
ACTIVE HALF-LIFE: ~ 46 HOURS
DOSAGE: 0.5–1 MG EVERY OTHER DAY
ACNE: LOW
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): LOW RISK
HEPATOTOXICITY: NONE
AROMATIZATION: BLOCKED
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: SELECTIVE ANDROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: CLOMIPHENE CITRATE
FORM: 100 TABLETS (50 MG/TABLET)
ACTIVE HALF-LIFE: ~ 5–7 DAYS
DOSAGE: 25–100 MG DAILY
ACNE: LOW
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): LOW RISK
HEPATOTOXICITY: LOW
AROMATIZATION: NONE
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
